{"id":"sodium-selenite","rwe":[{"pmid":"41905905","year":"2026","title":"[Selenium deficiency-associated macrocytic anemia in elderly patients receiving parenteral nutrition].","finding":"","journal":"[Rinsho ketsueki] The Japanese journal of clinical hematology","studyType":"Clinical Study"},{"pmid":"41895966","year":"2026","title":"Sodium selenite synergistic strategy based on myosin structural modification: Achieving soft selenium-enriched gel of large Yellow croaker surimi.","finding":"","journal":"Food research international (Ottawa, Ont.)","studyType":"Clinical Study"},{"pmid":"41864488","year":"2026","title":"Resveratrol protects lens epithelial cells and delays cataract development via inhibiting TXNIP mediated oxidative stress and apoptosis.","finding":"","journal":"Experimental eye research","studyType":"Clinical Study"},{"pmid":"41854407","year":"2026","title":"Dendrimer Nanogels with Built-in Free Radical Scavenging Enable Efficient Topical Delivery of a Hydrophilic Antioxidant to Restore Lens Redox Balance for Cataract Treatment.","finding":"","journal":"ACS applied materials & interfaces","studyType":"Clinical Study"},{"pmid":"41853698","year":"2026","title":"Selenotrisulfide delivery restores redox balance in myocardial infarction via a thiol-exchange reaction in situ.","finding":"","journal":"Bioactive materials","studyType":"Clinical Study"}],"tags":[{"label":"sodium selenite","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"A12CE02","category":"atc"},{"label":"Active","category":"status"},{"label":"Hyposelenemia","category":"indication"},{"label":"Fujimoto Pharmaceutical Corporation","category":"company"},{"label":"Micronutrients","category":"pharmacology"},{"label":"Trace Elements","category":"pharmacology"}],"phase":"discontinued","safety":{"safetySignals":[{"llr":102.965,"date":"","count":26,"signal":"Exposure during pregnancy","source":"DrugCentral FAERS","actionTaken":"Reported 26 times (LLR=103)"}],"commonSideEffects":[{"effect":"Exposure during pregnancy","drugRate":"LLR 103","severity":"common"}]},"trials":[],"aliases":[],"company":"Fujimoto Pharmaceutical Corporation","patents":[],"pricing":[],"allNames":"aselend","offLabel":[],"synonyms":["sodium selenite","disodium selenite","neoselen","sodium selenium oxide","selamin","aselend"],"timeline":[{"date":"2019-03-26","type":"positive","source":"DrugCentral","milestone":"PMDA approval (Fujimoto Pharmaceutical Corporation)"}],"approvals":[{"date":"2019-03-26","orphan":false,"company":"FUJIMOTO PHARMACEUTICAL CORPORATION","regulator":"PMDA"}],"brandName":"Aselend","ecosystem":[{"indication":"Hyposelenemia","otherDrugs":[],"globalPrevalence":null}],"mechanism":{"modality":"Small Molecule","drugClass":"sodium selenite","explanation":"Selenium is an essential mineral that helps protect cells from damage, supports the immune system, and is involved in the production of thyroid hormones. Aselend helps to replenish selenium levels in the body, which can become depleted due to various factors such as poor diet or certain medical conditions. This can help to alleviate symptoms of hyposelenemia and support overall health.","oneSentence":"Aselend works by providing the body with selenium, an essential mineral that plays a crucial role in various bodily functions.","technicalDetail":"Aselend, a sodium selenite compound, acts as a selenium supplement, increasing selenium levels in the body through oral administration. The exact mechanism of selenium supplementation is complex and involves the incorporation of selenium into selenoproteins, which play critical roles in various cellular processes."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4782","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=SODIUM%20SELENITE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=SODIUM SELENITE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:39:41.180008","biosimilars":[],"competitors":[{"drugName":"sodium selenate","drugSlug":"sodium-selenate","fdaApproval":"","relationship":"same-class"}],"genericName":"sodium selenite","indications":{"approved":[{"name":"Hyposelenemia","source":"DrugCentral","snomedId":83920001,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"sodium-selenate","brandName":"sodium selenate","genericName":"sodium selenate","approvalYear":"","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT05682261","phase":"NA","title":"The Effect of Multiple Micronutrient Supplements in Reducing Anemia in Women of Reproductive Age","status":"COMPLETED","sponsor":"Ethiopian Public Health Institute","startDate":"2023-03-23","conditions":["Anemia"],"enrollment":265,"completionDate":"2023-10-17"},{"nctId":"NCT05708183","phase":"","title":"Healthy Mums, Healthy Babies: Multiple Micronutrient Supplementation in Ethiopia","status":"RECRUITING","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2023-01-01","conditions":["Birth Weight"],"enrollment":25620,"completionDate":"2025-08-31"},{"nctId":"NCT02184533","phase":"PHASE1","title":"Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic Cancer","status":"COMPLETED","sponsor":"Stanford University","startDate":"2014-07","conditions":["Adenocarcinoma of the Prostate","Hormone-resistant Prostate Cancer","Recurrent Prostate Cancer","Stage IV Prostate Cancer","Multiple Myeloma","Plasmacytoma"],"enrollment":15,"completionDate":"2018-05"},{"nctId":"NCT02393183","phase":"PHASE2,PHASE3","title":"The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease (TED)","status":"WITHDRAWN","sponsor":"Iran University of Medical Sciences","startDate":"2019-07-15","conditions":["Thyroid Eye Disease"],"enrollment":0,"completionDate":"2022-12-15"},{"nctId":"NCT05451576","phase":"NA","title":"Sodium Selenite Supplementation in Patients With Head and Neck Cancer","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2020-08-12","conditions":["Head and Neck Squamous Cell Carcinoma","Selenium","Sodium Selenite"],"enrollment":60,"completionDate":"2024-06-30"},{"nctId":"NCT04201561","phase":"PHASE3","title":"High Dose Inorganic Selenium for Preventing Chemotherapy Induced Peripheral Neuropathy","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2019-12-24","conditions":["Chemotherapy-induced Peripheral Neuropathy","Recurrent Ovarian Carcinoma","Ovarian Cancer","Fallopian Tube Cancer","Primary Peritoneal Carcinoma"],"enrollment":68,"completionDate":"2024-12-31"},{"nctId":"NCT05523115","phase":"NA","title":"An Exploratory Investigation of a Supplement to Promote Cognitive Health Benefits","status":"COMPLETED","sponsor":"Heights","startDate":"2022-06-15","conditions":["Anxiety","Stress","Memory Deficits","Cortisol Overproduction"],"enrollment":34,"completionDate":"2022-10-01"},{"nctId":"NCT02832648","phase":"PHASE3","title":"Selenium for Musculoskeletal Health","status":"COMPLETED","sponsor":"Sheffield Teaching Hospitals NHS Foundation Trust","startDate":"2017-01","conditions":["Osteoporosis"],"enrollment":123,"completionDate":"2020-01-31"},{"nctId":"NCT04296578","phase":"PHASE1","title":"Study Evaluating Sodium Selenite in Combination With Abiraterone in Castrate Resistant Prostate Cancer Progressing on Abiraterone","status":"WITHDRAWN","sponsor":"Stanford University","startDate":"2020-10","conditions":["Prostate Cancer","Castrate Resistant Prostate Cancer"],"enrollment":0,"completionDate":"2023-10"},{"nctId":"NCT02002247","phase":"PHASE3","title":"SodiUm SeleniTe Adminstration IN Cardiac Surgery (SUSTAIN CSX®-Trial).","status":"UNKNOWN","sponsor":"Daren K. Heyland","startDate":"2015-01","conditions":["Heart Disease"],"enrollment":1400,"completionDate":"2021-07"},{"nctId":"NCT04189874","phase":"NA","title":"Stool Testing With Molecular Assay to Minimize Contact Precautions","status":"COMPLETED","sponsor":"Giulio DiDiodato","startDate":"2019-12-18","conditions":["Infectious Gastroenteritis"],"enrollment":156,"completionDate":"2021-02-12"},{"nctId":"NCT03081949","phase":"PHASE4","title":"Peripartum Cardiomyopathy in Nigeria Registry","status":"COMPLETED","sponsor":"Aminu Kano Teaching Hospital","startDate":"2017-06-12","conditions":["Peripartum Cardiomyopathy"],"enrollment":100,"completionDate":"2019-12-31"},{"nctId":"NCT02505295","phase":"NA","title":"Selenium and Ischemic Stroke Outcome","status":"COMPLETED","sponsor":"Mazandaran University of Medical Sciences","startDate":"2015-10","conditions":["Ischemic Stroke"],"enrollment":44,"completionDate":"2018-01"},{"nctId":"NCT02530788","phase":"PHASE3","title":"High-dose Selenium Supplementation in Patients With Left Ventricular Assist","status":"COMPLETED","sponsor":"RWTH Aachen University","startDate":"2015-08","conditions":["Ventricular Dysfunction, Left"],"enrollment":21,"completionDate":"2018-01"},{"nctId":"NCT01390506","phase":"PHASE2","title":"Selenium to Improve Neurological Outcome After Cardiac Arrest","status":"WITHDRAWN","sponsor":"Medical University of Graz","startDate":"2017-01","conditions":["Cardiac Arrest"],"enrollment":0,"completionDate":"2019-07"},{"nctId":"NCT02377635","phase":"PHASE1,PHASE2","title":"Selenium and Arsenic Pharmacodynamics","status":"COMPLETED","sponsor":"University of Saskatchewan","startDate":"2015-02-10","conditions":["Arsenic Poisoning Chronic"],"enrollment":40,"completionDate":"2017-01-19"},{"nctId":"NCT03230396","phase":"NA","title":"Vitamin Gum Pharmacokinetics","status":"COMPLETED","sponsor":"Penn State University","startDate":"2014-10-13","conditions":["Nutrient Pharmacokinetics"],"enrollment":15,"completionDate":"2015-07-01"},{"nctId":"NCT02026856","phase":"","title":"Therapeutic Effect of Sodium Selenite on Oxidative Stress in Patients With Severe Sepsis","status":"COMPLETED","sponsor":"Pavol Jozef Safarik University","startDate":"2013-12","conditions":["Severe Sepsis"],"enrollment":4,"completionDate":"2013-12"},{"nctId":"NCT01155791","phase":"PHASE1","title":"Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer","status":"TERMINATED","sponsor":"Sandy Srinivas","startDate":"2010-04","conditions":["Urologic Neoplasms","Prostate Cancer","Prostate Cancer Metastatic Disease"],"enrollment":2,"completionDate":"2012-10"},{"nctId":"NCT01473914","phase":"PHASE3","title":"Trace Element Replenishment Study in Hemodialysis Patients","status":"COMPLETED","sponsor":"Marcello Tonelli","startDate":"2012-11","conditions":["End Stage Renal Disease"],"enrollment":150,"completionDate":"2014-01"},{"nctId":"NCT00832039","phase":"PHASE3","title":"Placebo Controlled Trial of Sodium Selenite and Procalcitonin Guided Antimicrobial Therapy in Severe Sepsis","status":"COMPLETED","sponsor":"Kompetenznetz Sepsis","startDate":"2009-11","conditions":["Severe Sepsis","Septic Shock"],"enrollment":1089,"completionDate":"2013-06"},{"nctId":"NCT00875173","phase":"PHASE3","title":"Selenium Treatment and Chagasic Cardiopathy (STCC)","status":"UNKNOWN","sponsor":"Oswaldo Cruz Foundation","startDate":"2008-10","conditions":["Chagas Disease"],"enrollment":130,"completionDate":"2020-12"},{"nctId":"NCT02066610","phase":"NA","title":"Effect of Selenium Supplementation on Trace Mineral Antioxidant Enzyme and Amino Acid Metabolism in Infants","status":"COMPLETED","sponsor":"Abbott Nutrition","startDate":"1991-03","conditions":["Preterm Infants"],"enrollment":47,"completionDate":"1993-06"},{"nctId":"NCT01959438","phase":"PHASE1,PHASE2","title":"Sodium Selenite as a Cytotoxic Agent in Advanced Carcinoma","status":"UNKNOWN","sponsor":"Karolinska University Hospital","startDate":"2007-02","conditions":["Malignant Tumor","Treatment Resistant Disorders","Tumor Progression"],"enrollment":32,"completionDate":"2018-06"},{"nctId":"NCT01442727","phase":"PHASE3","title":"Selenium in the Treatment of Arsenic Toxicity and Cancers","status":"COMPLETED","sponsor":"Texas Tech University","startDate":"2006-12","conditions":["Arsenical Melanosis","Arsenical Keratosis","Arsenical Cancers","Arsenicosis","Arsenic Exposure","Arsenic Toxicity","Arsenic Poisoning"],"enrollment":819,"completionDate":"2009-04"},{"nctId":"NCT00188604","phase":"PHASE2","title":"The Use of Selenium to Treat Secondary Lymphedema - Breast Cancer","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2004-01","conditions":["Breast Neoplasms","Lymphedema"],"enrollment":34,"completionDate":"2009-01"},{"nctId":"NCT00207844","phase":"PHASE2","title":"Selenium, as Sodium Selenite, in the Treatment of Septic Shock","status":"COMPLETED","sponsor":"Centre Hospitalier de Meaux","startDate":"2002-01","conditions":["Septic Shock","Severe Sepsis"],"enrollment":60,"completionDate":"2005-01"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NUI":"N0000148373","MMSL":"35913","NDDF":"005523","UNII":"HIW548RQ3W","VUID":"4020869","CHEBI":"CHEBI:48843","VANDF":"4020869","RXNORM":"56519","UMLSCUI":"C0142923","ChEMBL_ID":"CHEMBL112302","KEGG_DRUG":"D10530","PUBCHEM_CID":"24934","MESH_DESCRIPTOR_UI":"D018038"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"present","companyName":"Fujimoto Pharmaceutical Corporation","relationship":"Current Owner"}],"publicationCount":0,"therapeuticAreas":["Immunology"],"atcClassification":{"source":"DrugCentral","atcCode":"A12CE02","allCodes":["A12CE02"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026","pmid":"41905905","title":"[Selenium deficiency-associated macrocytic anemia in elderly patients receiving parenteral nutrition].","journal":"[Rinsho ketsueki] The Japanese journal of clinical hematology"},{"date":"2026 May 31","pmid":"41895966","title":"Sodium selenite synergistic strategy based on myosin structural modification: Achieving soft selenium-enriched gel of large Yellow croaker surimi.","journal":"Food research international (Ottawa, Ont.)"},{"date":"2026 Mar 20","pmid":"41864488","title":"Resveratrol protects lens epithelial cells and delays cataract development via inhibiting TXNIP mediated oxidative stress and apoptosis.","journal":"Experimental eye research"},{"date":"2026 Mar 19","pmid":"41854407","title":"Dendrimer Nanogels with Built-in Free Radical Scavenging Enable Efficient Topical Delivery of a Hydrophilic Antioxidant to Restore Lens Redox Balance for Cataract Treatment.","journal":"ACS applied materials & interfaces"},{"date":"2026 Aug","pmid":"41853698","title":"Selenotrisulfide delivery restores redox balance in myocardial infarction via a thiol-exchange reaction in situ.","journal":"Bioactive materials"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"discontinued","companyName":"Fujimoto Pharmaceutical Corporation","companyId":"fujimoto-pharmaceutical-corporation","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Aselend is a small molecule compound with the synonyms including Disodium selenite. It is also known as Disodium selenite, Selenious acid disodium salt, and other related names.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"JP","regulator":"PMDA","status":"approved","approval_date":"2019-03-26T00:00:00.000Z","mah":"FUJIMOTO PHARMACEUTICAL CORPORATION","brand_name_local":null,"application_number":""}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}